• March 30, 2020
  • EFSA

Public consultation on the Draft Scientific Committee guidance on the assessment of aneugenicity


Your substances

None


EFSA's Scientific Committee has launched an open consultation on a Scientific Committee guidance on the assessment of aneugenicity. This document discusses the most appropriate in vivo follow-up for substances that are found to be aneugenic in vitro and how should the risk to human health be assessed for aneugenic substances.

CONTINUE READING ON www.efsa.europa.eu

                   

Related News

Loading...